The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ovarian Cancer-Global Market Insights and Sales Trends 2024
Synopsis
Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
The global Ovarian Cancer market size is expected to reach US$ 3397.3 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Ovarian Cancer in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Ovarian Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ovarian Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ovarian Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ovarian Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ovarian Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ovarian Cancer covered in this report include Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, Novogen, Genentech, Aetera Zenteris, Boehringer Ingelheim and Roche, etc.
The global Ovarian Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Global Ovarian Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ovarian Cancer market, Segment by Type:
Surgery
Chemotherapy
Radiation
Biological Therapy
Global Ovarian Cancer market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ovarian Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
The global Ovarian Cancer market size is expected to reach US$ 3397.3 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Ovarian Cancer in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Ovarian Cancer market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ovarian Cancer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ovarian Cancer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ovarian Cancer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ovarian Cancer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ovarian Cancer covered in this report include Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, Novogen, Genentech, Aetera Zenteris, Boehringer Ingelheim and Roche, etc.
The global Ovarian Cancer market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Global Ovarian Cancer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ovarian Cancer market, Segment by Type:
Surgery
Chemotherapy
Radiation
Biological Therapy
Global Ovarian Cancer market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ovarian Cancer companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Ovarian Cancer
1.1 Ovarian Cancer Market Overview
1.1.1 Ovarian Cancer Product Scope
1.1.2 Ovarian Cancer Market Status and Outlook
1.2 Global Ovarian Cancer Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Ovarian Cancer Market Size by Region (2018-2029)
1.4 Global Ovarian Cancer Historic Market Size by Region (2018-2023)
1.5 Global Ovarian Cancer Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Ovarian Cancer Market Size (2018-2029)
1.6.1 North America Ovarian Cancer Market Size (2018-2029)
1.6.2 Europe Ovarian Cancer Market Size (2018-2029)
1.6.3 Asia-Pacific Ovarian Cancer Market Size (2018-2029)
1.6.4 Latin America Ovarian Cancer Market Size (2018-2029)
1.6.5 Middle East & Africa Ovarian Cancer Market Size (2018-2029)
2 Ovarian Cancer Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Chemotherapy
2.1.3 Radiation
2.1.4 Biological Therapy
2.2 Global Ovarian Cancer Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Ovarian Cancer Historic Market Size by Type (2018-2023)
2.2.2 Global Ovarian Cancer Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Ovarian Cancer Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Ovarian Cancer Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Ovarian Cancer Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Ovarian Cancer Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Ovarian Cancer Revenue Breakdown by Type (2018-2029)
3 Ovarian Cancer Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Ovarian Cancer Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Ovarian Cancer Historic Market Size by Application (2018-2023)
3.2.2 Global Ovarian Cancer Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Ovarian Cancer Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Ovarian Cancer Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Ovarian Cancer Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Ovarian Cancer Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Ovarian Cancer Revenue Breakdown by Application (2018-2029)
4 Ovarian Cancer Competition Analysis by Players
4.1 Global Ovarian Cancer Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ovarian Cancer as of 2022)
4.3 Date of Key Players Enter into Ovarian Cancer Market
4.4 Global Top Players Ovarian Cancer Headquarters and Area Served
4.5 Key Players Ovarian Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 Ovarian Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol Myers Squibb
5.1.1 Bristol Myers Squibb Profile
5.1.2 Bristol Myers Squibb Main Business
5.1.3 Bristol Myers Squibb Ovarian Cancer Products, Services and Solutions
5.1.4 Bristol Myers Squibb Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol Myers Squibb Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Ovarian Cancer Products, Services and Solutions
5.2.4 Eli Lilly Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Ovarian Cancer Products, Services and Solutions
5.3.4 GlaxoSmithKline Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.3.5 Janssen Pharmaceuticals Recent Developments
5.4 Janssen Pharmaceuticals
5.4.1 Janssen Pharmaceuticals Profile
5.4.2 Janssen Pharmaceuticals Main Business
5.4.3 Janssen Pharmaceuticals Ovarian Cancer Products, Services and Solutions
5.4.4 Janssen Pharmaceuticals Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.4.5 Janssen Pharmaceuticals Recent Developments
5.5 Novogen
5.5.1 Novogen Profile
5.5.2 Novogen Main Business
5.5.3 Novogen Ovarian Cancer Products, Services and Solutions
5.5.4 Novogen Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.5.5 Novogen Recent Developments
5.6 Genentech
5.6.1 Genentech Profile
5.6.2 Genentech Main Business
5.6.3 Genentech Ovarian Cancer Products, Services and Solutions
5.6.4 Genentech Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.6.5 Genentech Recent Developments
5.7 Aetera Zenteris
5.7.1 Aetera Zenteris Profile
5.7.2 Aetera Zenteris Main Business
5.7.3 Aetera Zenteris Ovarian Cancer Products, Services and Solutions
5.7.4 Aetera Zenteris Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.7.5 Aetera Zenteris Recent Developments
5.8 Boehringer Ingelheim
5.8.1 Boehringer Ingelheim Profile
5.8.2 Boehringer Ingelheim Main Business
5.8.3 Boehringer Ingelheim Ovarian Cancer Products, Services and Solutions
5.8.4 Boehringer Ingelheim Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.8.5 Boehringer Ingelheim Recent Developments
5.9 Roche
5.9.1 Roche Profile
5.9.2 Roche Main Business
5.9.3 Roche Ovarian Cancer Products, Services and Solutions
5.9.4 Roche Ovarian Cancer Revenue (US$ Million) & (2018-2023)
5.9.5 Roche Recent Developments
6 North America
6.1 North America Ovarian Cancer Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Ovarian Cancer Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ovarian Cancer Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ovarian Cancer Market Dynamics
11.1 Ovarian Cancer Industry Trends
11.2 Ovarian Cancer Market Drivers
11.3 Ovarian Cancer Market Challenges
11.4 Ovarian Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
